Person: HAKYEMEZ, İSMAİL NECATİ
Search Results
Linezolid Versus Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus Keratitis in Rabbits
2013-07-01T00:00:00Z, Tas, Tekin, Kucukbayrak, Abdulkadir, Hakyemez, Ismail N., Mengeloglu, Firat Z., SIMAVLI, Huseyin, Ozyalvacli, Gulzade, Erdurmus, Mesut, HAKYEMEZ, İSMAİL NECATİ
Purpose: To compare the efficacy of topical linezolid (LZD) 1 mg/mL or 2 mg/mL to vancomycin (VA) 50 mg/mL for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) keratitis in rabbits.
High antimicrobial resistance and isolated pathogens in outpatient elderly population with urinary tract symptom
2012-01-01T00:00:00Z, Kucukbayrak, Abdulkadir, Hakyemez, Ismail Necati, Tas, Tekin, Alcelik, Aytekin, Kemahli, Eray, Duran, Arif, Aydemir, Bilge, Kocoglu, Esra, HAKYEMEZ, İSMAİL NECATİ
Background: In this study, antibiotic sensitivities and uropathogens isolated from elderly outpatients to have least one urinary tract symptom were evaluated.
Nosocomial Acinetobacter baumannii infections and changing Antibiotic Resistance
2013-09-01T00:00:00Z, Hakyemez, Ismail Necati, Kucukbayrak, Abdulkadir, Tas, Tekin, Yikilgan, Aslihan Burcu, Akkaya, Akcan, Yasayacak, Aliye, Akdeniz, Hayrettin, HAKYEMEZ, İSMAİL NECATİ
Objectives: In the intensive care setting, Acinetobacter baumannii causes ventilator-associated pneumonia and other nosocomial infections that are difficult to treat. Objective of this study was to investigate nosocomial A. baumannii infections and its changing antibiotic resistance.
Evaluation of patients with Tularemia in Bolu province in northwestern Anatolia, Turkey
2014-03-01T00:00:00Z, Mengeloglu, Zafer, Duran, Arif, Hakyemez, Ismail Necati, Ocak, Tarik, Kucukbayrak, Abdulkadir, KARADAG, Mustafa, Tas, Tekin, Akdeniz, Hayrettin, HAKYEMEZ, İSMAİL NECATİ
Introduction: Tularemia is a zoonotic disease caused by Francisella tularensis. Here we present an epidemic occurring in Bolu province, located in northwestern Anatolia in Turkey, and some features of the cases.
Determining immunoassay cutoff value using Western blot results to predict hepatitis C infection in blood donors with low-titer anti-HCV reactivity
2013-07-01T00:00:00Z, Kucukbayrak, Abdulkadir, CAKMAK, Saadet, Hakyemez, Ismail Necati, Tas, Tekin, Akdeniz, Hayrettin, HAKYEMEZ, İSMAİL NECATİ
Since the 1990s, blood donors have been scanned for anti-hepatitis C virus (anti-HCV) antibodies, which can be defined by enzyme immunoassay as a screening test. In this population, false-reactive ratios have been high. Recently, some authors have aimed to find a cutoff value for anti-HCV different from those established by test manufacturers to predict HCV infection. In this study, 321 patients, after two repeating tests, had reactive results in s/co 2.61 s/co, with 74.1 % sensitivity and 71.6 % specificity (area under the curve, 0.820; 95 % confidence interval, 0.753 to 0.887). We suggest that an effective cutoff value for anti-HCV other than that established by the manufacturer cannot be assigned to predict hepatitis C infection for blood donors in low-prevalence areas.